상품상세정보

-   목  차   -

 

 

Part 1. PET역사와 국내외 PET현황 / 1

Chapter 01. PET역사와 국내외 PET현황····················································· 3
1. 임상PET의 역사············································································· 3
2. 한국에서 임상 PET 도입···································································· 3
3. 한국에서 임상 PET의 도약································································· 4
4. 한국의 임상 PET의 전망···································································· 5
5. 결론····························································································· 5
6. 참고 문헌······················································································· 5

Part 2. PET/CT 기기와 영상분석 / 7

Chapter 01. PET/CT 기기와 영상분석························································ 9
1. 서론······························································································ 9
2. 기본원리······················································································· 10
3. PET 및 PET/CT 시스템···································································· 12
4. 데이터 획득··················································································· 14
5. 영상 재구성··················································································· 16
6. 영상보정······················································································· 18
7. 정량분석 및 추적자동역학·································································22
8. 참고문헌·······················································································25

Part 3. PET 방사성의약품과 사이클로트론 / 27

Chapter 01. PET 방사성의약품과 사이클로트론··········································· 29
1. PET용 방사성의약품· ························· 30
2. PET용 방사성의약품의 품질관리····················· 44
3. 사이클로트론····························· 47
viii 임상 PET
4. 발생기· ······························· 49
5. 사이클로트론실의 구성 및 주요장비· ·················· 51
6. 참고문헌······························· 52

Part 4. PET 임상적용 / 55

Chapter 01. 뇌혈관 질환과 간질 PET························································57
1. 뇌신경 PET· ····························· 57
2. 뇌혈관질환의 PET· ·························· 61
3. 간질의 PET· ····························· 63
4. 참고문헌· ······························ 68
Chapter 02. 치 매··············································································· 71
1. FDG PET· ······························ 71
2. 아밀로이드 판 영상··························· 76
3. 참고문헌······························· 80
Chapter 03. 파킨슨병 PET···································································· 83
1. PET검사 종류· ···························· 83
2. PET의 임상적용 ···························· 90
3. 참고문헌······························· 94
Chapter 04. 심근관류 PET·····································································97
1. 서론·································· 97
2. 심근관류 PET 방사성의약품 및 영상법· ················· 98
3. 심근관류 PET의 임상응용························101
4. 참고문헌· ····························· 102
Chapter 05. 심근대사 PET··································································· 103
1. 심근대사 영상· ··························· 103
2. 심근관류 PET을 이용한 생존심근 진단· ················ 106
3. 참고문헌······························ 108
Chapter 06. 심장의 분자영상································································· 111
1. 서론·································· 111
2. 죽상경화증에서 PET 분자영상······················ 111
3. 심부전의 PET 분자영상·························114
4. 참고문헌· ······························ 115
목 차 ix
Chapter 07. 폐암 PET·········································································117
1. 배경·································· 117
2. 참고 문헌· ······························122
Chapter 08. 유방암 PET······································································ 123
1. 배경································· 123
2. 진단 및 병기결정··························· 124
3. 치료효과 판정 및 예측· ························126
4. 재발 평가· ······························127
5. 기타································ 128
6. 결론·································129
7. 참고문헌 · ····························· 130
Chapter 09. 대장암 PET·······································································131
1. 배경·································· 131
2. 진단 및 병기결정 · ·························· 131
3. 치료효과 판정 및 예측· ······················· 133
4. 재발 평가· ····························· 134
5. 결론································ 135
6. 참고문헌······························ 135
Chapter 10. 부인암 PET······································································ 137
1. 서론··································137
2. 자궁경부암과 PET· ························· 138
3. 난소암과 PET· ····························141
4. 자궁내막암· ···························· 143
5. 기타 부인암· ···························· 144
6. 참고문헌 · ····························· 145
Chapter 11. 갑상선암 PET··································································· 147
1. 배경································· 147
2. FDG PET· ····························· 147
3. 124I PET································ 151
4. 기타 PET ······························· 151
5. 참고문헌·······························152
Chapter 12. 두경부암 PET··································································· 153
1. 배경································· 153
2. 진단 및 병기결정 · ························· 154
x 임상 PET
3. 치료 효과 판정 및 예측························ 158
4. 재발 평가· ····························· 160
5. 방사선치료계획 (RT planning)····················· 161
6. FDG 이외의 방사성의약품························162
7. 참고문헌·······························162
Chapter 13. 뇌종양 PET······································································ 165
1. 서론··································165
2. 진단 및 예후 평가· ··························167
3. 치료방침 결정· ··························· 170
4. 재발 평가· ······························ 171
5. 뇌종양 PET에서 기타 고려 사항· ····················172
6. 참고문헌·······························173
Chapter 14. 식도암 PET······································································ 175
1. 배경··································175
2. 진단 및 병기 결정 ···························176
3. 치료 효과판정 및 예측· ························178
4. 재발 평가 및 재병기결정· ·······················179
5. 방사선치료계획 수립· ·························179
6. 결론·································179
7. 참고문헌······························ 180
Chapter 15. 위암 PET········································································ 183
1. 배경································· 183
2. 진단 및 병기 결정 ·························· 183
3. 치료 효과 판정 및 예측························ 185
4. 재발 평가· ····························· 185
5. 결론································ 186
6. 참고문헌······························ 186
Chapter 16. 간담췌암 PET··································································· 187
1. 췌장암과 PET· ····························187
2. 담도계 종양과 PET·························· 190
3. 분자영상의 새로운 시도························· 191
4. 참고문헌· ······························192
Chapter 17. 흑색종 PET······································································ 193
1. 배 경· ······························· 193
목 차 xi
2. 진단································ 194
3. 병기결정······························ 194
4. 예후 예측· ······························195
5. 재발 평가 및 재발 시 병기결정·····················195
6. 치료효과 판정 및 조기예측· ······················196
7. 참고문헌·······························196
Chapter 18. 비뇨기암 PET··································································· 199
1. 배경 ·································199
2. 전립선암 PET· ····························199
3. 방광암 PET· ···························· 200
4. 신장암 PET· ···························· 202
5. 결론 · ······························· 203
6. 참고문헌 · ····························· 203
Chapter 19. 원인미상암 PET······························································· 205
1. 서론································· 205
2. 일반적 진단 과정 · ························· 206
3. 양전자단층촬영술·························· 206
4. 결론· ······························· 208
5. 참고문헌······························ 209
Chapter 20. 감염 PET·········································································211
1. 서론·································· 211
2. 골수염································ 211
3. 합병증을 동반한 당뇨병성 족부병변 ·················· 213
4. 통증을 동반한 하지 인공관절· ···················· 213
5. 연부조직 감염· ··························· 214
6. 감염 치료평가에서 PET의 유용성· ···················216
7. 결론 · ································217
8. 참고문헌·······························217
Chapter 21. FDG 이외 종양 PET··························································· 221
1. 아미노산 PET(Amino acid PET)·····················221
2. 펩티드수용체 PET(Peptide receptor PET)· ·············· 222
3. 항체 PET (Antibody PET)· ····················· 224
4. 핵산 PET (Nucleic acid PET)····················· 224
5. 저산소증 PET (Hypoxia PET)····················· 225
xii 임상 PET
6. 세포막 PET (Membrane PET)····················· 226
7. 기타································ 227
8. 참고문헌······························ 229
Chapter 22. 림프종 PET······································································ 231
1. 배경································· 231
2. 진단 및 병기 결정· ························· 232
3. 치료 효과 판정···························· 233
4. 병기 재결정과 예후 예측 ······················· 235
5. 재발 발견· ····························· 236
6. 기타································ 236
7.결론································· 236
8.참고문헌······························· 237

Part 5. PET실용 / 239

Chapter 01. PET 정도관리와 프로토콜····················································· 241
1. 정도관리······························· 241
2. PET 정도관리 프로그램 - 외국의 사례 ················ 243
3. PET 정도관리 프로그램과 대표적 기준 ················· 244
4. 국내 PET 정도관리 체계, 관련 기관 및 법률적 고려사항· ········ 246
5. PET 정도관리의 국내기준과 진행 현황· ················ 246
6. 결론································ 249
7. 참고문헌······························ 250
Chapter 02. PET 검사의 방사선 안전······················································ 253
1. 방사선량학적인 고려· ························ 253
2. PET/CT 방사선피폭의 특성· ····················· 254
3. PET/CT로 인한 피폭· ························ 255
4. 결론· ······························· 255
5. 참고문헌······························ 256
Chapter 03. PET 방사선량평가······························································ 259
1. 방사선량 단위· ··························· 259
2. 방사선 내부 피폭선량 계산 (MIRD 방법)· ··············· 260
3. OLINDA/EXM 소프트웨어를 이용한 PET 영상기반 피폭선량 계산····· 263
4. 참고문헌· ····························· 264
목 차 xiii
Chapter 04. PET 신의료기술인정과 규제 및 보험급여··································· 265
1. PET 신의료기술인정· ························ 265
2. 의료보험 적용 ···························· 267
3. 참고문헌······························ 269
Part 6. PET 이용연구와 PET의 미래 / 271
Chapter 01. 소동물 PET······································································ 273
1. 필요성································ 273
2. 시스템 특성 ····························· 273
3. 시스템 사양· ···························· 274
4. 기타 고려사항· ··························· 274
5. 참고문헌······························ 277
Chapter 02. 분자영상과 신약개발··························································· 279
1. 신약개발 과정에서 PET의 역할···················· 280
2. 대리표지자로서 PET· ························ 280
3. 동반진단검사로서 PET· ······················· 282
4. PET을 이용한 약력학························· 283
5. PET을 이용한 약동학························· 283
6. 약물전달 효과를 평가하는 PET· ··················· 285
7. 유전자치료 모니터링· ························ 285
8. 세포 치료 모니터링·························· 286
9. 참고문헌······························ 287
Chapter 03. 하이브리드 PET································································ 289
1. 융합영상의 필요성· ························· 289
2. PET/MRI 시스템····························291
3. MRI 기능성 정보 ADC· ······················· 294
4. 병렬형 전신 PET/MRI 시스템 임상경험················· 294
5. 저산소증 PET/MRI와 MR 초분극분광법················ 296
6. 전망································ 297
7. 참고문헌······························ 298
색인 한글·································· 301
영문·································· 312
기타·································· 319

 

상품결제정보

배송정보

• 배송 방법 : 택배
• 배송 지역 : 전국지역
• 배송 비용 : 2,500원
• 배송 기간 : 3일 ~ 5일
• 배송 안내 :

  
  

고객님께서 저희 성보의학서적에서 주문을 하신 주문번호가 생성이 되면 그에 따른 발송준비 및 배송절차는 다음과 같습니다

- 일반적으로 배송기간은 입금확인일로부터 3일 이내 배송을 원칙으로 합니다. 이는 재고가 확보된 도서의 경우입니다.
(단, 산간이나 지방 및 도서지역의 경우 약 1~2일이 더 소요될 수 있습니다.)
- 배송의 시점은 고객님의 주문 이후 입금확인 과정을 거쳐 배송이 됩니다.
- 주문도서의 배송 시 휴일이 포함된 경우는 24시간 순연됩니다.
- 배송료는 회원주문, 비회원주문 모두 2,500원 입니다. (일부 도서 및 산간지역은 추가 배송비 발생)
- 주문 금액이 30,000원 이상일 경우에는 무료로 배송해 드립니다.
- 반품/취소.환불 시 배송비는 무료로 배송이 되었을 경우, 처음 발생한 배송비까지 소급 적용될 수 있으며,
상품 하자로 인한 도서 교환시에는 무료로 가능합니다.
- 성보의학서적의 기본배송방법으로 택배서비스(한진택배&우체국)를 이용합니다.





해외원서의 경우
- 국내에서 재고를 보유한 업체가 없는 경우 해외주문을 해야 하는 상황이 생깁니다.
이 경우 4~5주 안에 공급이 가능하며 현지 출판사 사정에 따라 구입이 어려운 경우 2~3주 안에 공지해 드립니다.
- 재고 유무는 주문 전 사이트 상에서 배송 안내 문구로 구분 가능하며, 필요에 따라 전화 문의 주시면 거래처를 통해
다시 한번 국내재고를 확인해 드립니다.

- 해외 주문 도서는 고객님의 요청에 의해 주문하는 '개인주문' 상품으로, 단순한 고객변심/착오로 인한 취소, 교환, 반품은 불가능합니다.
- 해외주문 시 도서가격 및 수입 제반 비용 등을 모두 선결제로 진행하고 재고 관련 등의 사유로 취소, 교환, 반품이 불가능하오니
이점 꼭 숙지하시고 해외주문시 신중하게 주문하여 주시기 바랍니다.

교환 및 반품정보

반품안내
전자상거래에 의한 소비자보호에 관한 법률에 의거 반품 가능 기간내에는 반품을 요청하실 수 있습니다.

반품가능기간
- 단순변심 : 물품 수령 후 14일 이내 (단, 고객님의 요청으로 주문된 해외원서 제외)

- 주문하신 것과 다른 상품을 받으신 경우

- 파본인 상품을 받으신 경우
- 배송과정에서 손상된 상품을 받으신 경우

- 개봉된 DVD, CD-ROM, 카세트테이프 (단, 배송 중 파손된 상품 제외)

- 탐독의 흔적이 있는 경우
- 소비자의 실수로 상품이 훼손된 경우
- 고객님의 주문으로 수입된 해외 도서인 경우
- 수령일로 14일 지난 상품의 경우

- 해외 주문 도서는 고객님의 요청에 의해 주문하는 '개인주문' 상품으로, 단순한 고객변심/착오로 인한 취소, 교환, 반품은 불가능합니다.
- 해외주문 시 도서가격 및 수입 제반 비용 등을 모두 선결제로 진행하고 재고 관련 등의 사유로 취소, 교환, 반품이 불가능하오니
  이점 꼭 숙지하시고 해외주문시 신중하게 주문하여 주시기 바랍니다.

반품절차
- 배송완료후 3일 이내에 고객센터 02-854-2738 혹은 1:1 문의게시판을 통해 교환 및 반품 의사를 알려주세요.
- 도서는 택배 또는 등기우편으로 보내주시기 바랍니다.
- 14일 이내에 교환/반품/환불 받으실 상품이 회수되어야 하며, 반품과 환불의 경우 상품주문시 면제받으셨던
  배송비와 반품배송비까지 고객님께서 부담하시게 됩니다.

반품주소
(10881) 서울시 구로구 구로중앙로26길 32(구로동) 1층(성보의학서적)
전화) 02-854-2738

환불방법
- 대금은 반품 확인 후에, 카드취소/ 적립금 지급/ 계좌로 환불조치 해 드립니다.
- 카드결제 시 카드 승인취소절차를 밟게 되며 무통장입금시 현금 환불 혹은 적립금으로 변환 가능합니다.
- 반품도서와 함께 도서명, 주문번호와 환불계좌번호를 알려주시면 빠른 처리 가능합니다.

서비스문의

고객센터: (02)854-2738